Skip to content

Effect of Longmu Gegen Decoction on herpes zoster and its effect on T cell subsets

Effect of Longmu Gegen Decoction on herpes zoster and its effect on T cell subsets

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049522
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster

Interventions

Sponsors

Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the typical diagnostic criteria for herpes zoster; the time from onset to visit is 1-3 days; 2. Pain vas score less than 6 points; age between 18 and 80 years old; untreated; 3. No cognitive impairment; voluntary subjects and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to traditional Chinese medicine or unwilling to treat with traditional Chinese medicine; 2. Patients with severe heart, lung and other systemic diseases and malignant tumors; patients with immune diseases such as systemic lupus erythematosus and those who use immunosuppressants; pregnant and lactating women and those with a history of mental illness; 3. Serious adverse reactions and known allergies to the drug during taking the drug; participate in other clinical investigators.

Design outcomes

Primary

MeasureTime frame
T cell subsets (CD3+, CD3+CD4+, CD3+CD8+);

Countries

China

Contacts

Public ContactFu Zhongxue

Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences

fzxpersonal@aliyun.com+86 13811982053

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026